PD
MXCT icon

Point72 (DIFC)’s MaxCyte MXCT Stock Holding History

Point72 (DIFC)’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.71K Buy
+2,348
New +$4.08K ﹤0.01% 1025

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 (DIFC)'s MXCT Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in MaxCyte (MXCT) in Q3 2025: 2,348 shares worth $3.71K. The stake represents ﹤0.01% of the portfolio and ranks #1025 among its holdings.

112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Point72 (DIFC) held 2,348 shares of MaxCyte worth $3.71K as of Q3 2025.
  • MaxCyte was a new Point72 (DIFC) position in Q3 2025.
  • MaxCyte made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1025 holding.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.